CARBIDOPA
Generic: CARBIDOPA, LEVODOPA AND ENTACAPONE
Rising Pharma HoldingsManufacturer
ORALRoute
CARBIDOPAActive Substance
2022-01-25Original Approval
CARBIDOPA is FDA application ANDA213212, sponsored by RISING. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2025-10-07
Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising PharmaProduct mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and
Class II2021-07-29
Entacapone Tablets, USP, 200 mg, Rx only, 30 Tablets per unit dose cartons, Distributed by: Major Pharmaceuticals, 17177Failed Dissolution Specifications
Top Reported Reactions
1
HALLUCINATION
545 reports
2
FALL
541 reports
3
DYSKINESIA
508 reports
4
DEATH
392 reports
5
DRUG INEFFECTIVE
390 reports
6
PARKINSON^S DISEASE
323 reports
7
CONFUSIONAL STATE
291 reports
8
GAIT DISTURBANCE
283 reports
9
TREMOR
278 reports
10
ON AND OFF PHENOMENON
261 reports